Total Payments
$20,881
2024 Payments
$2,649
Companies
65
Transactions
1,556
Medicare Patients
5,569
Medicare Billing
$627,893
Payment Breakdown by Category
Food & Beverage$20,642 (98.9%)
Education$238.32 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,642 | 1,544 | 98.9% |
| Education | $238.32 | 12 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,437 | 216 | $0 (2024) |
| ABBVIE INC. | $2,009 | 139 | $0 (2024) |
| PFIZER INC. | $1,692 | 163 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,364 | 97 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,280 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,135 | 85 | $0 (2024) |
| Lilly USA, LLC | $1,104 | 98 | $0 (2024) |
| Astellas Pharma US Inc | $995.04 | 62 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $847.03 | 90 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $718.98 | 61 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,649 | 146 | ABBVIE INC. ($351.09) |
| 2023 | $2,070 | 130 | Novo Nordisk Inc ($389.22) |
| 2022 | $2,446 | 167 | ABBVIE INC. ($592.30) |
| 2021 | $2,800 | 178 | AbbVie Inc. ($462.46) |
| 2020 | $2,236 | 164 | AstraZeneca Pharmaceuticals LP ($280.69) |
| 2019 | $2,668 | 229 | Novo Nordisk Inc ($279.88) |
| 2018 | $2,829 | 249 | AstraZeneca Pharmaceuticals LP ($320.62) |
| 2017 | $3,183 | 293 | Boehringer Ingelheim Pharmaceuticals, Inc. ($362.45) |
All Payment Transactions
1,556 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Genetic Disease | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Biological | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $104.80 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,547 | 2,273 | $408,750 | $163,897 |
| 2022 | 14 | 1,152 | 1,902 | $353,307 | $151,575 |
| 2021 | 20 | 1,356 | 2,086 | $363,511 | $166,239 |
| 2020 | 25 | 1,514 | 2,318 | $374,639 | $146,182 |
Total Patients
5,569
Total Services
8,579
Medicare Billing
$627,893
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 459 | 880 | $213,840 | $69,644 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 355 | 355 | $88,040 | $43,385 | 49.3% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 62 | 267 | $46,794 | $22,939 | 49.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $11,660 | $6,166 | 52.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 78 | 79 | $11,599 | $5,604 | 48.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 24 | $9,312 | $3,554 | 38.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 287 | 341 | $3,410 | $2,849 | 83.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 33 | $4,950 | $2,353 | 47.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 79 | $4,578 | $2,259 | 49.4% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 21 | 21 | $4,843 | $2,070 | 42.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 36 | 43 | $5,250 | $1,586 | 30.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,232 | $629.20 | 51.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 18 | $2,116 | $546.50 | 25.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 18 | $558.00 | $161.84 | 29.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 65 | 71 | $568.00 | $152.24 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 473 | 1,003 | $213,061 | $74,896 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 246 | 246 | $57,006 | $30,465 | 53.4% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 52 | 195 | $29,250 | $18,220 | 62.3% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 47 | 119 | $13,090 | $7,358 | 56.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 69 | 69 | $9,548 | $4,716 | 49.4% |
| 99327 | New patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 30 | 30 | $6,000 | $3,953 | 65.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 21 | $7,224 | $3,277 | 45.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $5,638 | $3,064 | 54.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,792 | $1,912 | 50.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 69 | $3,792 | $1,861 | 49.1% |
About Danilo Corales
Danilo Corales is a Internal Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013951771.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Danilo Corales has received a total of $20,881 in payments from pharmaceutical and medical device companies, with $2,649 received in 2024. These payments were reported across 1,556 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($20,642).
As a Medicare-enrolled provider, Corales has provided services to 5,569 Medicare beneficiaries, totaling 8,579 services with total Medicare billing of $627,893. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lexington, KY
- Active Since 06/15/2006
- Last Updated 12/02/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013951771
Products in Payments
- Ozempic (Drug) $850.32
- TRELEGY ELLIPTA (Drug) $833.79
- FARXIGA (Drug) $795.50
- VRAYLAR (Drug) $758.99
- JARDIANCE (Drug) $748.58
- UBRELVY (Drug) $702.71
- NURTEC ODT (Drug) $673.86
- XARELTO (Drug) $578.74
- MYRBETRIQ (Drug) $545.42
- CHANTIX (Drug) $536.99
- REXULTI (Drug) $523.19
- TRINTELLIX (Drug) $464.91
- TRULICITY (Drug) $448.82
- TROKENDI XR (Drug) $372.95
- QULIPTA (Drug) $336.51
- ELIQUIS (Drug) $320.64
- Rybelsus (Drug) $317.81
- Saxenda (Drug) $298.98
- XIFAXAN (Drug) $277.39
- ENTRESTO (Drug) $258.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Internal Medicine $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452